These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 2163325

  • 1. Removal of partial agonism from parathyroid hormone (PTH)-related protein-(7-34)NH2 by substitution of PTH amino acids at positions 10 and 11.
    Nutt RF, Caulfield MP, Levy JJ, Gibbons SW, Rosenblatt M, McKee RL.
    Endocrinology; 1990 Jul; 127(1):491-3. PubMed ID: 2163325
    [Abstract] [Full Text] [Related]

  • 2. Treatment of bone-derived ROS 17/2.8 cells with dexamethasone and pertussis toxin enables detection of partial agonist activity for parathyroid hormone antagonists.
    McKee RL, Caulfield MP, Rosenblatt M.
    Endocrinology; 1990 Jul; 127(1):76-82. PubMed ID: 2163326
    [Abstract] [Full Text] [Related]

  • 3. The 7-34-fragment of human hypercalcemia factor is a partial agonist/antagonist for parathyroid hormone-stimulated cAMP production.
    McKee RL, Goldman ME, Caulfield MP, DeHaven PA, Levy JJ, Nutt RF, Rosenblatt M.
    Endocrinology; 1988 Jun; 122(6):3008-10. PubMed ID: 2836181
    [Abstract] [Full Text] [Related]

  • 4. Inhibition by (D-Trp12,Tyr34)bPTH(7-34)amide of PTH and PTHrP effects on Pi transport in renal cells.
    Pizurki L, Rizzoli R, Bonjour JP.
    Am J Physiol; 1990 Aug; 259(2 Pt 2):F389-92. PubMed ID: 2167018
    [Abstract] [Full Text] [Related]

  • 5. A new highly potent parathyroid hormone antagonist: [D-Trp12,Tyr34]bPTH-(7-34)NH2.
    Goldman ME, McKee RL, Caulfield MP, Reagan JE, Levy JJ, Gay CT, DeHaven PA, Rosenblatt M, Chorev M.
    Endocrinology; 1988 Nov; 123(5):2597-9. PubMed ID: 2844517
    [Abstract] [Full Text] [Related]

  • 6. Modifications of position 12 in parathyroid hormone and parathyroid hormone related protein: toward the design of highly potent antagonists.
    Chorev M, Goldman ME, McKee RL, Roubini E, Levy JJ, Gay CT, Reagan JE, Fisher JE, Caporale LH, Golub EE.
    Biochemistry; 1990 Feb 13; 29(6):1580-6. PubMed ID: 2334716
    [Abstract] [Full Text] [Related]

  • 7. The human PTH2 receptor: binding and signal transduction properties of the stably expressed recombinant receptor.
    Behar V, Pines M, Nakamoto C, Greenberg Z, Bisello A, Stueckle SM, Bessalle R, Usdin TB, Chorev M, Rosenblatt M, Suva LJ.
    Endocrinology; 1996 Jul 13; 137(7):2748-57. PubMed ID: 8770894
    [Abstract] [Full Text] [Related]

  • 8. The role of protein kinase-A activity in the evaluation of agonist/antagonist properties of analogs of parathyroid hormone-related protein in opossum kidney cells.
    Martin KJ, McConkey CJ, Caulfield MP.
    Endocrinology; 1992 Nov 13; 131(5):2161-4. PubMed ID: 1330493
    [Abstract] [Full Text] [Related]

  • 9. Dissociation of cAMP accumulation and phosphate uptake in opossum kidney (OK) cells with parathyroid hormone (PTH) and parathyroid hormone related protein (PTHrP).
    Muff R, Caulfield MP, Fischer JA.
    Peptides; 1990 Nov 13; 11(5):945-9. PubMed ID: 2178252
    [Abstract] [Full Text] [Related]

  • 10. Inactivation by plasma may be responsible for lack of efficacy of parathyroid hormone antagonists in hypercalcemia of malignancy.
    Kukreja SC, D'Anza JJ, Wimbiscus SA, Fisher JE, McKee RL, Caulfield MP, Rosenblatt M.
    Endocrinology; 1994 May 13; 134(5):2184-8. PubMed ID: 8156920
    [Abstract] [Full Text] [Related]

  • 11. Functional properties of a synthetic chicken parathyroid hormone-related protein 1-36 fragment.
    Schermer DT, Bradley MS, Bambino TH, Nissenson RA, Strewler GJ.
    J Bone Miner Res; 1994 Jul 13; 9(7):1041-6. PubMed ID: 7942150
    [Abstract] [Full Text] [Related]

  • 12. Mono- and bicyclic analogs of parathyroid hormone-related protein. 1. Synthesis and biological studies.
    Bisello A, Nakamoto C, Rosenblatt M, Chorev M.
    Biochemistry; 1997 Mar 18; 36(11):3293-9. PubMed ID: 9116007
    [Abstract] [Full Text] [Related]

  • 13. Non-homologous sequences of parathyroid hormone and the parathyroid hormone related peptide bind to a common receptor on ROS 17/2.8 cells.
    Abou-Samra AB, Uneno S, Jueppner H, Keutmann H, Potts JT, Segre GV, Nussbaum SR.
    Endocrinology; 1989 Oct 18; 125(4):2215-7. PubMed ID: 2551642
    [Abstract] [Full Text] [Related]

  • 14. Conformational studies of a potent Leu11,D-Trp12-containing lactam-bridged parathyroid hormone-related protein-derived antagonist.
    Maretto S, Schievano E, Mammi S, Bisello A, Nakamoto C, Rosenblatt M, Chorev M, Peggion E.
    J Pept Res; 1998 Sep 18; 52(3):241-8. PubMed ID: 9774237
    [Abstract] [Full Text] [Related]

  • 15. Cyclic AMP formation in rat bone and kidney cells is stimulated equally by parathyroid hormone-related protein (PTHrP) 1-34 and PTH 1-34.
    Blind E, Raue F, Knappe V, Schroth J, Ziegler R.
    Exp Clin Endocrinol; 1993 Sep 18; 101(3):150-5. PubMed ID: 8223983
    [Abstract] [Full Text] [Related]

  • 16. Interspecies comparison of renal cortical receptors for parathyroid hormone and parathyroid hormone-related protein.
    Orloff JJ, Goumas D, Wu TL, Stewart AF.
    J Bone Miner Res; 1991 Mar 18; 6(3):279-87. PubMed ID: 1852088
    [Abstract] [Full Text] [Related]

  • 17. A midregion parathyroid hormone-related peptide mobilizes cytosolic calcium and stimulates formation of inositol trisphosphate in a squamous carcinoma cell line.
    Orloff JJ, Ganz MB, Nathanson MH, Moyer MS, Kats Y, Mitnick M, Behal A, Gasalla-Herraiz J, Isales CM.
    Endocrinology; 1996 Dec 18; 137(12):5376-85. PubMed ID: 8940360
    [Abstract] [Full Text] [Related]

  • 18. The bovine renal parathyroid hormone (PTH) receptor has equal affinity for two different amino acid sequences: the receptor binding domains of PTH and PTH-related protein are located within the 14-34 region.
    Caulfield MP, McKee RL, Goldman ME, Duong LT, Fisher JE, Gay CT, DeHaven PA, Levy JJ, Roubini E, Nutt RF.
    Endocrinology; 1990 Jul 18; 127(1):83-7. PubMed ID: 2163327
    [Abstract] [Full Text] [Related]

  • 19. Influence of the amino-terminus on in vitro and in vivo biological activity of synthetic parathyroid hormone-like peptides of malignancy.
    Rabbani SA, Mitchell J, Roy DR, Hendy GN, Goltzman D.
    Endocrinology; 1988 Dec 18; 123(6):2709-16. PubMed ID: 2848683
    [Abstract] [Full Text] [Related]

  • 20. Studies of the N-terminal region of a parathyroid hormone-related peptide (1-36) analog: receptor subtype-selective agonists, antagonists, and photochemical cross-linking agents.
    Carter PH, Jüppner H, Gardella TJ.
    Endocrinology; 1999 Nov 18; 140(11):4972-81. PubMed ID: 10537121
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.